CLINICAL TRIALS PROFILE FOR MEPIVACAINE HYDROCHLORIDE
✉ Email this page to a colleague
All Clinical Trials for MEPIVACAINE HYDROCHLORIDE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00121329 ↗ | 4% Intrauterine Lidocaine Infusion for Pain Management in First Trimester Abortions | Completed | Oregon Health and Science University | N/A | 1969-12-31 | Recent studies have investigated the use of local anesthetics (i.e. lidocaine, mepivacaine) to lessen the pain experienced with minor gynecologic procedures such as endometrial biopsy and office hysteroscopy. Local anesthetic injected into the uterine cavity has been demonstrated effective in some studies at decreasing patient pain associated with these intrauterine procedures at an anesthetic concentration of at least 2%. Based on this evidence, we hypothesized that an intrauterine lidocaine infusion may reduce patient pain during first trimester abortions. |
| NCT00154167 ↗ | Safety and Efficacy Study of NV-101 in Dental Patients | Completed | Novalar Pharmaceuticals, Inc. | Phase 2 | 2003-02-01 | The purpose of this study was: - to determine if NV-101 accelerates recovery from numbness compared to placebo - to evaluate safety of NV-101 |
| NCT00567450 ↗ | Ropivacaine Versus Ropivacaine Plus Mepivacaine for Sciatic Block | Completed | Centre Hospitalier Universitaire, Amiens | Phase 4 | 2007-09-01 | In loco regional anesthesia, much more than for general anesthesia, the choice of the product is largely left at the discretion of the practitioner. Two categories of local anesthetics are distinguished according to their pharmacodynamic characteristics: products with a short time of installation and a short duration period, and products with a longer delay of installation of the sensitive and motor block, but with a long-term duration. Indeed, the combined use of two products pharmacodynamically different seems to be of a practical interest. This study provides a comparison of the onset of action of 30 ml of ropivacaine 0.75% and 30ml of a mixture of ropivacaïne 0.75% associated with mepivacaïne 1.5% for the subgluteal sciatic nerve block. This is a prospective randomized double-blind study where the main criterion of judgment is the time of installation of a sensitive block compatible with surgery in the sciatic territory nerve. Fifteen patients per group were calculated to detect a 50% decrease of the onset of action in the combination group with a power of 90% and alpha to 5%, according to a previous pilot study. The secondary endpoints are the intensity and time of installation of the motor block, the duration of sensitive and motor block, the total dose of morphine administered within 48 hours, as well as its possible side effects. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for MEPIVACAINE HYDROCHLORIDE
Condition Name
Clinical Trial Locations for MEPIVACAINE HYDROCHLORIDE
Trials by Country
Clinical Trial Progress for MEPIVACAINE HYDROCHLORIDE
Clinical Trial Phase
Clinical Trial Sponsors for MEPIVACAINE HYDROCHLORIDE
Sponsor Name
